IBO vs PH · rev $18.0K vs P/E 28, rev $19.85B
Impact BioMedical, Inc. (IBO) versus Parker-Hannifin Corporation (PH) — a side-by-side from cached financials, not a winner call.
Impact BioMedical, Inc. (IBO) is a biotechnology company listed on US.
Parker-Hannifin Corporation (PH) is a specialty industrial machinery company listed on US.
Latest reported IBO revenue for 2025-09-30 was $18.0K. Net income was -$1.5M. IBO currently screens at market cap $7.6M.
Latest reported PH revenue for 2025-06-30 was $19.85B. Net income was $3.53B. PH currently screens at market cap $91.89B and trailing P/E 27.7.
IBO currently screens at market cap $7.6M. PH currently screens at market cap $91.89B and trailing P/E 27.7.
Not investment advice. Open the IBO and PH stock pages for the full models.
Not investment advice.